SCHEMBL12377005

SCHEMBL12377005

COc1c(C=O)cccc1OP

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
TLR2 O60603 1/20 0.53
ERN1 O75460 1/20 0.53
TLR1 Q15399 1/20 0.53
TLR6 Q9Y2C9 1/20 0.53
SRC P12931 1/20 0.53
NFE2L2 Q16236 5/20 0.47
ALDH1A1 P00352 3/20 0.46
CYP1A2 P05177 3/20 0.46
LMNA P02545 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
PRMT1 Q99873 1/20 0.45
HPGD P15428 2/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Veratraldehyde SCHEMBL28289918 0.86 SRC (0.67) CA1CA2TLR2ERN1TLR1
O-Veratraldehyde SCHEMBL29923149 0.86 SRC (0.67) CA1CA2TLR2ERN1TLR1
O-Veratraldehyde SCHEMBL319070 0.86 SRC (0.67) CA1CA2TLR2ERN1TLR1
SCHEMBL12904379 0.85 SRC (0.61) CA1CA2TLR2ERN1TLR1
SCHEMBL14906870 0.83 CA1 (0.46) CA1CA2TLR2ERN1TLR1
SCHEMBL2787203 0.82 CA1 (0.73) CA1CA2TLR2ERN1TLR1
SCHEMBL4683638 0.81 CA1 (0.53) CA1CA2TLR2ERN1TLR1
O-Veratraldehyde SCHEMBL8706125 0.80 SRC (0.59) CA1CA2TLR2ERN1TLR1
SCHEMBL2277795 0.80 CA1 (0.56) CA1CA2TLR2ERN1TLR1
O-Veratraldehyde SCHEMBL28143507 0.80 SRC (0.64) CA1CA2TLR2ERN1TLR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170042844-A1 BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID PHARMA CINQ, LLC 2017-02-16 US disclosed
US-20170042844-A1 BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID PHARMA CINQ, LLC 2017-02-16 US disclosed
US-9115072-B2 Compounds and method for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2015-08-25 US disclosed
US-9115072-B2 Compounds and method for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2015-08-25 US disclosed
US-8889724-B2 Tetrazole compounds for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2014-11-18 US disclosed
US-8889724-B2 Tetrazole compounds for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2014-11-18 US disclosed
US-20140142185-A1 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid WELLSTAT THERAPEUTICS CORPORATION 2014-05-22 US disclosed
US-20140142185-A1 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid WELLSTAT THERAPEUTICS CORPORATION 2014-05-22 US disclosed
US-20130259850-A1 COMPOUNDS AND METHOD FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORPORATION (US) 2013-10-03 US disclosed
US-20130259850-A1 COMPOUNDS AND METHOD FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORPORATION (US) 2013-10-03 US disclosed
US-8410154-B2 Tetrazole compounds for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2013-04-02 US disclosed
US-8410154-B2 Tetrazole compounds for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2013-04-02 US disclosed
US-20110206653-A1 TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORPORATION (US) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130259850-A1 COMPOUNDS AND METHOD FOR REDUCING URIC ACID RCC2, HAX1, SLC10A6 CA1 447/4885CA2 666/4885TLR2 3003/4885
US-20110206653-A1 TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID FPR1, CASP1, PON1 CA1 154/4885CA2 260/4885TLR2 1975/4885
US-20170042844-A1 BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID FPR1, FFAR1, GLS CA1 591/4885CA2 369/4885TLR2 1061/4885
US-20140142185-A1 3-Benzyloxyphenyloxoacetic Acid Compounds for Reducing Uric Acid GLS, FPR1, PFAS CA1 1391/4885CA2 598/4885TLR2 1737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.